Xenetic Biosciences, Inc.

DB:3XB0 Voorraadrapport

Marktkapitalisatie: €5.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Xenetic Biosciences Beheer

Beheer criteriumcontroles 3/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Jeff Eisenberg

Algemeen directeur

US$632.8k

Totale compensatie

Percentage CEO-salaris63.9%
Dienstverband CEO5.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn6.3yrs
Gemiddelde ambtstermijn bestuur4.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Jeff Eisenberg's beloning veranderd ten opzichte van Xenetic Biosciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$633kUS$404k

-US$7m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$750kUS$368k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$446kUS$350k

-US$11m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$603kUS$300k

-US$18m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$318kUS$300k

-US$7m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$815kUS$300k

-US$4m

Sep 30 2017n/an/a

-US$12m

Jun 30 2017n/an/a

-US$13m

Mar 31 2017n/an/a

-US$58m

Dec 31 2016US$694kUS$25k

-US$58m

Compensatie versus markt: Jeff's total compensation ($USD632.83K) is above average for companies of similar size in the German market ($USD418.12K).

Compensatie versus inkomsten: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Eisenberg (57 yo)

5.8yrs

Tenure

US$632,827

Compensatie

Mr. Jeffrey F. Eisenberg, also known as Jeff, Esq., has been the Chief Executive Officer of Xenetic Biosciences, Inc. since October 26, 2017; has been its Director since July 11, 2016 and also serves as it...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jeffrey Eisenberg
CEO, President & Director5.8yrsUS$632.83kgeen gegevens
James Parslow
CFO, COO & Corporate Secretary6.3yrsUS$473.99k0%
€ 0
Curtis Lockshin
Chief Scientific Officer6.6yrsUS$470.37k0%
€ 0

6.3yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: 3XB0's management team is seasoned and experienced (6.3 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jeffrey Eisenberg
CEO, President & Director7.1yrsUS$632.83kgeen gegevens
Adam Logal
Independent Chairman of the Board6yrsUS$59.56k0%
€ 0
Roger Kornberg
Independent Director7.5yrsUS$59.56k0%
€ 0
Firdaus Dastoor
Independent Director9.6yrsUS$59.56k0%
€ 0
James Callaway
Independent Director6yrsUS$59.56k0%
€ 0
Guenther Koehne
Member of Scientific Advisory Board4.3yrsgeen gegevensgeen gegevens
Matthew Frigault
Member of Scientific Advisory Board4.6yrsgeen gegevensgeen gegevens
Alexey Vinogradov
Independent Director4.1yrsUS$59.56k1.23%
€ 61.4k
Grigory Borisenko
Independent Non-Executive Director3.9yrsUS$59.56kgeen gegevens
Maksim Mamonkin
Member of Scientific Advisory Board3.5yrsgeen gegevensgeen gegevens
Allan Tsung
Member of Scientific Advisory Board1.3yrsgeen gegevensgeen gegevens
Jonathan Spicer
Member of Scientific Advisory Boardless than a yeargeen gegevensgeen gegevens

4.4yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: 3XB0's board of directors are considered experienced (4.4 years average tenure).